Melanoma Vaccine
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
504
NCT01546571
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Phase: Phase 3
Role: Lead Sponsor
Start: May 1, 2012
Completion: Jun 30, 2021
Loading map...